6533b82ffe1ef96bd1295a73

RESEARCH PRODUCT

TCT-441 Optical Coherence Tomography assessment of the implantation of Everolimus-Eluting Bioresorbable Scaffolds against angiographic assessment: the clinical outcomes

Stephen HamshereAndrew WraggDaniel A. JonesCharles KnightRoshan WeerackodyAlex ByrneAnthony Mathur

subject

medicine.medical_specialtyEverolimusmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionStentequipment and suppliessurgical procedures operativeOptical coherence tomographymedicinecardiovascular diseasesRadiologyCardiology and Cardiovascular MedicinebusinessBioresorbable scaffoldmedicine.drug

description

Bioresorbable Vascular Scaffolds (BVS) are the newest generation of stents for use during Percutaneous Coronary Intervention. However, as history has demonstrated, each development in stent technology has been associated with its own specific complications. With BVS, there are reports that recoil is

https://doi.org/10.1016/j.jacc.2016.09.576